[OPNT] YoY Quarter Result on 30-Apr-2017 [#Q1]

Stock
[OPNT] Opiant Pharmaceuticals, Inc.
Announcement Date
14-Jun-2017
Financial Year
2017
Quarter
30-Apr-2017 [#Q1]
Profit Trend
QoQ- -129.39%
YoY- -852.40%
Quarter Report
OPNT's Result
OPNT's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 30/04/17 30/04/16 30/04/15 30/04/14 CAGR
Revenue 4,199 3,826 1,703 18 2,605 120 0 -
PBT -1,646 -1,736 -9,311 -3,130 416 -1,851 -554 20.18%
Tax 39 -122 33 25 4 -14 0 -
NP -1,685 -1,736 -9,344 -3,130 416 -1,851 -554 20.65%
Tax Rate - - - - -1.03% - - -
Total Cost 5,883 5,562 11,047 3,148 2,189 1,971 554 49.01%
Ratio Analysis
31/03/20 31/03/19 31/03/18 30/04/17 30/04/16 30/04/15 30/04/14 CAGR
NP Margin -40.12 -45.37 -548.68 -17,275.38 15.97 -1,542.25 0.00 -
Per Share
31/03/20 31/03/19 31/03/18 30/04/17 30/04/16 30/04/15 30/04/14 CAGR
EPS -0.40 -0.44 -3.68 -1.55 0.22 -1.01 -0.31 4.39%
EPS Diluted -0.40 -0.44 -3.68 -1.55 0.15 -1.01 -0.31 4.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.